Adding Targeted Agent to Perioperative Therapy for RCC May Improve Disease Control

Published Date: 12 Nov 2024

More IKCS news: Long-term survival benefit with nivolumab/ipilimumab, disease-slowing surgery

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Long Wait Times on the Other Side of the Pond: King Charles' Cancer Diagnosis.

2.

Chemo causes lasting physical decline in breast cancer survivors

3.

New study reveals racial disparities in breast cancer diagnosis and outcomes in Canada

4.

'Full House' Star's Cancer; Fluoride Fears Go Mainstream; Florida Doctor Arrested

5.

Recent Rise in Early-Onset Solid Tumors Is Associated with Accelerated Aging.


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot